BioFabUSA, a program of ARMI, is a public-private partnership with more than 170 members, including companies, academic institutions and not-for profit organizations.

The ISSCR 2026 Annual Meeting brings together nearly 3,500 scientists, clinicians, industry leaders, and innovators from around the world to share the latest discoveries in stem cell research and regenerative medicine.
Recognized as the leading international event for the stem cell community, ISSCR provides a forum for scientific exchange, collaboration, and discussion across a broad range of topics, including clinical applications, disease modeling and drug discovery, engineering biology, ethics and policy, and somatic stem cell research.
ARMI will attend ISSCR 2026 to engage with researchers, clinicians, industry partners, and innovators advancing the science and translation of regenerative medicine. The meeting offers an opportunity to explore emerging technologies, strengthen collaborations, and gain insights into the scientific advancements that will shape the future of advanced therapies and their path to commercialization.
Join the global stem cell community in Montréal for four days of groundbreaking science, networking, and collaboration.